257 related articles for article (PubMed ID: 18024433)
21. Role of inhibitory BCR co-receptors in immunity.
Tsubata T
Infect Disord Drug Targets; 2012 Jun; 12(3):181-90. PubMed ID: 22394175
[TBL] [Abstract][Full Text] [Related]
22. Regulation of MHC class II signal transduction by the B cell coreceptors CD19 and CD22.
Bobbitt KR; Justement LB
J Immunol; 2000 Nov; 165(10):5588-96. PubMed ID: 11067914
[TBL] [Abstract][Full Text] [Related]
23. Src homology region 2 (SH2) domain-containing phosphatase-1 dephosphorylates B cell linker protein/SH2 domain leukocyte protein of 65 kDa and selectively regulates c-Jun NH2-terminal kinase activation in B cells.
Mizuno K; Tagawa Y; Mitomo K; Arimura Y; Hatano N; Katagiri T; Ogimoto M; Yakura H
J Immunol; 2000 Aug; 165(3):1344-51. PubMed ID: 10903736
[TBL] [Abstract][Full Text] [Related]
24. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection.
Cornall RJ; Cyster JG; Hibbs ML; Dunn AR; Otipoby KL; Clark EA; Goodnow CC
Immunity; 1998 Apr; 8(4):497-508. PubMed ID: 9586639
[TBL] [Abstract][Full Text] [Related]
25. CD22 is a negative regulator of B-cell receptor signalling.
Nitschke L; Carsetti R; Ocker B; Köhler G; Lamers MC
Curr Biol; 1997 Feb; 7(2):133-43. PubMed ID: 9016707
[TBL] [Abstract][Full Text] [Related]
26. N-Linked Glycosylation Regulates CD22 Organization and Function.
Wasim L; Buhari FHM; Yoganathan M; Sicard T; Ereño-Orbea J; Julien JP; Treanor B
Front Immunol; 2019; 10():699. PubMed ID: 31019513
[TBL] [Abstract][Full Text] [Related]
27. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.
Matsubara N; Imamura A; Yonemizu T; Akatsu C; Yang H; Ueki A; Watanabe N; Abdu-Allah H; Numoto N; Takematsu H; Kitazume S; Tedder TF; Marth JD; Ito N; Ando H; Ishida H; Kiso M; Tsubata T
Front Immunol; 2018; 9():820. PubMed ID: 29725338
[TBL] [Abstract][Full Text] [Related]
28. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
29. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
Yusa S; Catina TL; Campbell KS
J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
[TBL] [Abstract][Full Text] [Related]
30. Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity.
Ochi H; Watanabe T
Int Immunol; 2000 Oct; 12(10):1417-23. PubMed ID: 11007759
[TBL] [Abstract][Full Text] [Related]
31. Chicken Ig-like receptor B2, a member of a multigene family, is mainly expressed on B lymphocytes, recruits both Src homology 2 domain containing protein tyrosine phosphatase (SHP)-1 and SHP-2, and inhibits proliferation.
Viertlboeck BC; Crooijmans RP; Groenen MA; Göbel TW
J Immunol; 2004 Dec; 173(12):7385-93. PubMed ID: 15585863
[TBL] [Abstract][Full Text] [Related]
32. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1.
Bléry M; Kubagawa H; Chen CC; Vély F; Cooper MD; Vivier E
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2446-51. PubMed ID: 9482905
[TBL] [Abstract][Full Text] [Related]
33. SHP-1/immunoreceptor tyrosine-based inhibition motif-independent inhibitory signalling through murine natural killer cell receptor Ly-49A in a transfected B-cell line.
Motoda K; Takata M; Kiura K; Nakamura I; Harada M
Immunology; 2000 Jul; 100(3):370-7. PubMed ID: 10929060
[TBL] [Abstract][Full Text] [Related]
34. Cooperation between SHP-2, phosphatidyl inositol 3-kinase and phosphoinositol 5-phosphatase in the Fc gamma RIIb mediated B cell regulation.
Sármay G; Koncz G; Pecht I; Gergely J
Immunol Lett; 1999 May; 68(1):25-34. PubMed ID: 10397152
[TBL] [Abstract][Full Text] [Related]
35. Expression of B cell receptor-associated signaling molecules in human lupus.
Huck S; Le Corre R; Youinou P; Zouali M
Autoimmunity; 2001 May; 33(3):213-24. PubMed ID: 11683380
[TBL] [Abstract][Full Text] [Related]
36. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
[TBL] [Abstract][Full Text] [Related]
37. A role in B cell activation for CD22 and the protein tyrosine phosphatase SHP.
Doody GM; Justement LB; Delibrias CC; Matthews RJ; Lin J; Thomas ML; Fearon DT
Science; 1995 Jul; 269(5221):242-4. PubMed ID: 7618087
[TBL] [Abstract][Full Text] [Related]
38. CD19 and CD22 expression reciprocally regulates tyrosine phosphorylation of Vav protein during B lymphocyte signaling.
Sato S; Jansen PJ; Tedder TF
Proc Natl Acad Sci U S A; 1997 Nov; 94(24):13158-62. PubMed ID: 9371816
[TBL] [Abstract][Full Text] [Related]
39. KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).
Yusa S; Catina TL; Campbell KS
J Immunol; 2004 Jun; 172(12):7385-92. PubMed ID: 15187115
[TBL] [Abstract][Full Text] [Related]
40. Augmentation of signaling through BCR containing IgE but not that containing IgA due to lack of CD22-mediated signal regulation.
Sato M; Adachi T; Tsubata T
J Immunol; 2007 Mar; 178(5):2901-7. PubMed ID: 17312134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]